Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 25.91
+0.12 (0.47%)
At close: May 9, 2025, 2:57 PM CST
Enwei Pharmaceutical Revenue
Enwei Pharmaceutical had revenue of 196.50M CNY in the quarter ending March 31, 2025, with 7.10% growth. This brings the company's revenue in the last twelve months to 825.15M, up 7.46% year-over-year. In the year 2024, Enwei Pharmaceutical had annual revenue of 812.13M with 3.43% growth.
Revenue (ttm)
825.15M
Revenue Growth
+7.46%
P/S Ratio
3.20
Revenue / Employee
533.04K
Employees
1,548
Market Cap
2.64B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |